Sustainability| More...
 

Cancer Drugs

Genentech, Innovative Cancer Drug Maker, Receives $43.7B Offer From Roche Holding

New York Times | David Jolly | Posted 07.29.2008 | Business

Read More: Cancer, Genentech, Genentech Buyout, Cancer Drugs, Roche Holdings, Business News

PARIS -- The Swiss drug maker Roche Holding said Monday that it was offering about $43.7 billion to acquire the 44 percent of the biotechnology compan...

Read Whole Story

Medicare To Stop Paying For Two Cancer Drugs

New York Times | Alex Berenson | Posted 03.28.2008 | Business

Read More: Medicare Cancer, Bexxar, Medicare Cancer Drugs, Medicare, Cancer Drugs, Non-Hodgkins Lymphona, Lymphoma, Zevalin, Business News

New Medicare rules for a small but promising class of cancer drugs may cause thousands of lymphoma patients to lose access to the treatment, which in ...

Read Whole Story